CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us
  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Microgravity R&D
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Biotech Companies In Europe Top Swiss Biotech Companies - 2024 Top Swiss Biotech Companies - 2023 Top Biotech Companies in UK - 2023 Top Biotech Companies in Germany - 2023

Life Sciences Review

Biotech

Political Continuity Offers Little Clarity For Health Innovation

Political Continuity Offers Little Clarity For Health Innovation

Rudiger Schulze

Vice President and General Manager, DACH

Ultragenyx

Real-World Evidence Empowering Patient-Focused Medical Affairs

Jesper Lekdorf

VP Global Medical Affairs

Novo Nordisk [CPH: NOVO-B]

Featured Issue
#

Trusted data Foundations for Pharma R&D

Axel Dietrich, Global Head of Data Excellence CSL
#

Machine-Learning-Generated Insights from Health Data: Promise of Natural Language Processing

Kim Wager, Scientific Director Oxford PharmaGenesis
#

Pioneering Biosimilars with Expertise and Innovation

Gerrit Hagens, Director
#

The Future of Cognitive Wellness

Larisa Andreeva, Founder and CEO
Cell and Gene Therapy Navigating the Next Frontier in Biomanufacturing

Cell and Gene Therapy Navigating the Next Frontier in Biomanufacturing

Narayana Rao, Senior Vice President, Global Bioprocessing Commercial

Avantor

Biopreparaty: Altering Agriculture with Eco-Friendly Biofungicides

Altering Agriculture with Eco-Friendly Biofungicides

Ivana Suchankova, Business Manager

#

Clinically Proven Solutions for Thicker, Healthier Hair

Adrián Quiroga, CEO

Pharma Hermetic

News

Inventus welcomes senior figure from Google as a board adviser

Advancing Nutritional Recovery through Local Therapy

What Medical Device Sponsors Need From European CROs

Clinical-Stage Drug Developers Face Greater Pressure Around Development Planning in Europe

Loading...
#

Pioneering Solutions in the Biotech Landscape

Michael Hsu, Managing Director

#

Making Liquid Gold from Waste Bananas

Dr Andrew Lee, CEO

#

Revolutionizing Human Rejuvenation And Anti-Ageing

Prof. Alessio Lanna, PH.D., CEO And Chairman

#

Next-Gen Precision in Genetic Testing

Vadim Pospelov, CEO & Co-Founder

Pioneering Sustainable Cell Culture for Tomorrow’s Industries

Pioneering Sustainable Cell Culture for Tomorrow’s Industries

Dr. Teresa Buck, Head of Cell Innovations

Leading The Way In Personalised And Precise Cancer Treatments

Leading The Way In Personalised And Precise Cancer Treatments

DR. Ioannis Papasotiriou, MD, PHD, SCYM, Founder

#

Swiss Precision to Drive Global Immunoassay Innovation Excellence

Sonia Accossato, Senior Scientist and Business Development, BMA Biomedicals

News

Inventus welcomes senior figure from Google as a board adviser

European Innovations in Targeted Gene Therapy: Pioneering Precision Medicine

Interpreting Value in Biotech Asset Development Decisions

Controlled Release Technology Advances Drug Delivery Across Europe
Shaping the Future of Cell and Gene Therapy

Shaping the Future of Cell and Gene Therapy

Roderick de Greef, Chairman and Chief Executive Officer, BioLife Solutions

Clinical research in the UK: Increasing Inclusion, Accountability and Decreasing Waste.

Clinical research in the UK: Increasing Inclusion, Accountability and Decreasing Waste.

Jenny Rivers, Director of Research and Development, Barts Health NHS Trust

Building a Framework to Expand Access to Gene Therapies

Building a Framework to Expand Access to Gene Therapies

Stefano Baila, Managing Director, Support Biologics, Eurofins

Digital Innovation for Redesign Of Cardiovascular Care

Digital Innovation for Redesign Of Cardiovascular Care

Thomas Draper, , Vice President, Administrative Lead, Clinical Service Lines, Wellstar Health System

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-europe.lifesciencesrevieweurope.com